ArticleAnnals of medicine and surgery (2012)2025
Diagnostic patterns after adoption of shape-sensing robotic-assisted bronchoscopy: a retrospective cohort study.
Article in Annals of medicine and surgery (2012), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lung cancer is the leading cause of cancer-related deaths, due in part to the high proportion of late-stage diagnoses. Shape-sensing robotic-assisted bronchoscopy (ssRAB) is a novel bronchoscopic platform that enhances access to peripheral pulmonary lesions. However, its impact on diagnostic stage and procedural outcomes in clinical practice is not well established in the literature. This analysis assesses the impact of a new ssRAB program on these outcomes at a single site within an academic health system. Methods: A retrospective chart review of patients who underwent an ssRAB biopsy following an abnormal lung imaging study at a single center in the United States from September 2020 to December 2023. The primary outcome was diagnostic stage. Secondary outcomes included histopathological findings, nodule size, sensitivity, and intraoperative complications. Statistical analyses included descriptive statistics and logistic regression to evaluate diagnostic trends over time. Results: A total of 399 patients underwent ssRAB, with 397 (99.5%) receiving a tissue biopsy during this period. Diagnostic yield was 94.0% ( Conclusion: Implementation of an ssRAB platform was associated with an increased rate in early stage cancer diagnoses. These findings may suggest that integrating advanced bronchoscopic technologies into lung nodule evaluation pathways, including screening programs and expedited pulmonology referrals for incidental nodule findings, may enhance early diagnosis and improve clinical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.